{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:28:39Z","timestamp":1787801319735,"version":"build-2784847793"},"reference-count":34,"publisher":"IOP Publishing","issue":"34","license":[{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/page\/copyright"},{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["21774096"],"award-info":[{"award-number":["21774096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["Nanotechnology"],"published-print":{"date-parts":[[2024,8,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Although chlorambucil (CHL) is a long-established anticancer drug, the drug failure of CHL, mediated by the intracellular defense system consisting of glutathione (GSH) and GSH S-transferase pi (GST-pi), has significantly limited the application of CHL. To overcome this issue, we first designed a GSH-responsive small-molecule prodrug (EA-SS-CHL) by combining CHL and ethacrynic acid (EA). Subsequently, drug-loaded nanoparticles (ECPP) were formed by the self-assembly between EA-SS-CHL and amphiphilic PEG-PDLLA to improve the water solubility of the prodrug and its ability to target tumor sites. Upon exposure to high intracellular GSH concentration, EA-SS-CHL gradually degrades, leading to the release of EA and CHL. The presence of EA facilitates the depletion of GSH and inhibition of GST-pi, ultimately attenuating the detoxification of the intracellular defense system to CHL. Cytotoxicity studies and apoptosis assays demonstrate that ECPP exhibits higher therapeutic efficiency than CHL. Additionally, <jats:italic>in vivo<\/jats:italic> tumor suppression effects and biocompatibility provide further evidence for the superiority of ECPP. This work presents a promising strategy to enhance the efficacy of CHL in cancer therapy.<\/jats:p>","DOI":"10.1088\/1361-6528\/ad501a","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T22:21:06Z","timestamp":1716589266000},"page":"345601","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Dual approach: micellar delivery of chlorambucil prodrug with concurrent glutathione depletion and GST inhibition for enhanced anticancer activity"],"prefix":"10.1088","volume":"35","author":[{"given":"Shaojie","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuofei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8184-1247","authenticated-orcid":true,"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"266","published-online":{"date-parts":[[2024,6,7]]},"reference":[{"key":"nanoad501abib1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1124\/pharmrev.120.000121","article-title":"The nitrogen mustards","volume":"74","author":"Highley","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"nanoad501abib2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/575417","article-title":"Chlorambucil-induced acute interstitial pneumonitis","volume":"2014","author":"Shafqat","year":"2014","journal-title":"Case Rep. Hematol."},{"key":"nanoad501abib3","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2011.031","article-title":"Therapy-related myeloid neoplasms in chronic lymphocytic leukemia and Waldenstrom\u2019s macroglobulinemia","volume":"3","author":"Ricci","year":"2011","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"nanoad501abib4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2147\/PGPM.S407940","article-title":"Acute myeloid leukemia secondary to chronic lymphocytic leukemia after prolonged chlorambucil therapy: a case report","volume":"16","author":"Wu","year":"2023","journal-title":"Pharmgenomics Pers. Med."},{"key":"nanoad501abib5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.7326\/0003-4819-113-7-525","article-title":"Chronic lymphocytic leukemia: new insights into biology and therapy","volume":"113","author":"Foon","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"nanoad501abib6","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/ajh.26367","article-title":"Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures","volume":"96","author":"Hallek","year":"2021","journal-title":"Am. J. Hematol."},{"key":"nanoad501abib7","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1021\/tx950193h","article-title":"Cross-linking of human placenta \u03c0 class glutathione S-transferase dimer by chlorambucil","volume":"9","author":"Hathout","year":"1996","journal-title":"Chem. Res. Toxicol."},{"key":"nanoad501abib8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jmb.2008.04.066","article-title":"The anti-cancer drug chlorambucil as a substrate for the human polymorphic enzyme glutathione transferase P1-1: kinetic properties and crystallographic characterisation of allelic variants","volume":"380","author":"Parker","year":"2008","journal-title":"J. Mol. Biol."},{"key":"nanoad501abib9","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202310300","article-title":"Nanosensors monitor intracellular GSH depletion: GSH triggers Cu(II) for tumor imaging and inhibition","volume":"20","author":"Wang","year":"2024","journal-title":"Small"},{"key":"nanoad501abib10","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1021\/acsmaterialslett.3c01330","article-title":"l-Cysteine-triggered regulation of the mitochondrial energy metabolism to enhance chemotherapy of triple-negative breast cancer","volume":"6","author":"Ge","year":"2024","journal-title":"ACS Mater. Lett."},{"key":"nanoad501abib11","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/emboj\/18.5.1321","article-title":"Regulation of JNK signaling by GSTp","volume":"18","author":"Adler","year":"1999","journal-title":"EMBO J."},{"key":"nanoad501abib12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41389-017-0025-3","article-title":"Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases","volume":"7","author":"Allocati","year":"2018","journal-title":"Oncogenesis"},{"key":"nanoad501abib13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.bioactmat.2023.01.026","article-title":"H2O2-responsive polymer prodrug nanoparticles with glutathione scavenger for enhanced chemo-photodynamic synergistic cancer therapy","volume":"25","author":"Wang","year":"2023","journal-title":"Bioact. Mater."},{"key":"nanoad501abib14","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1039\/D2TB00989G","article-title":"Host-guest interaction-based supramolecular prodrug self-assemblies for GSH-consumption augmented chemotherapy","volume":"10","author":"Bai","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"nanoad501abib15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jconrel.2018.01.034","article-title":"Reactive oxygen species-responsive nanoprodrug with quinone methides-mediated GSH depletion for improved chlorambucil breast cancers therapy","volume":"274","author":"Luo","year":"2018","journal-title":"J. Control. Release"},{"key":"nanoad501abib16","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1021\/ja0432618","article-title":"Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance","volume":"127","author":"Ang","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"nanoad501abib17","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1002\/anie.202012687","article-title":"An ethacrynic acid-brominated BODIPY photosensitizer (EA-BPS) construct enhances the lethality of reactive oxygen species in hypoxic tumor-targeted photodynamic therapy","volume":"60","author":"Won","year":"2020","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"nanoad501abib18","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1016\/j.apsb.2021.10.013","article-title":"\u2018Pincer movement\u2019: reversing cisplatin resistance based on simultaneous glutathione depletion and glutathione S-transferases inhibition by redox-responsive degradable organosilica hybrid nanoparticles","volume":"12","author":"Niu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"nanoad501abib19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0167-4838(93)90245-M","article-title":"Interactions of glutathione S-transferase-pi with ethacrynic acid and its glutathione conjugate","volume":"1164","author":"Awasthi","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"nanoad501abib20","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3109\/00498259309059418","article-title":"Ethacrynic acid and its glutathione conjugate as inhibitors of glutathione S-transferases","volume":"23","author":"Ploemen","year":"1993","journal-title":"Xenobiotica"},{"key":"nanoad501abib21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jconrel.2021.02.031","article-title":"Polymeric micelles in drug delivery: an insight of the techniques for their characterization and assessment in biorelevant conditions","volume":"332","author":"Ghezzi","year":"2021","journal-title":"J. Control. Release"},{"key":"nanoad501abib22","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1038\/s41598-024-52143-y","article-title":"An approach for an enhanced anticancer activity of ferulic acid-loaded polymeric micelles via MicroRNA-221 mediated activation of TP53INP1 in caco-2 cell line","volume":"14","author":"Sweed","year":"2024","journal-title":"Sci. Rep."},{"key":"nanoad501abib23","doi-asserted-by":"publisher","first-page":"8221","DOI":"10.1002\/slct.202001905","article-title":"Solvent-assisted [(glycine)-(MP-SiO2NPs)] aggregate for drug loading and cancer therapy","volume":"5","author":"Amgoth","year":"2020","journal-title":"ChemistrySelect"},{"key":"nanoad501abib24","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1021\/acsbiomaterials.7b00523","article-title":"Tumor neovasculature-targeted APRPG-PEG-PDLLA\/MPEG-PDLLA mixed micelle loading combretastatin A-4 for breast cancer therapy","volume":"4","author":"Hao","year":"2018","journal-title":"ACS Biomater. Sci. Eng."},{"key":"nanoad501abib25","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1016\/j.apsb.2022.02.009","article-title":"A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation, apoptosis and M2 macrophages polarization","volume":"12","author":"Yang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"nanoad501abib26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10549-007-9591-y","article-title":"Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer","volume":"108","author":"Lee","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"nanoad501abib27","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jconrel.2024.03.019","article-title":"A quantitative MRI-based approach to estimate the permeation and retention of nanomedicines in tumors","volume":"368","author":"Nomani","year":"2024","journal-title":"J. Control. Release"},{"key":"nanoad501abib28","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.1021\/jm040790d","article-title":"Design and synthesis of a nitrogen mustard derivative stabilized by apo-neocarzinostatin","volume":"47","author":"Urbaniak","year":"2004","journal-title":"J. Med. Chem."},{"key":"nanoad501abib29","doi-asserted-by":"publisher","first-page":"6175","DOI":"10.1016\/j.biomaterials.2013.04.056","article-title":"Suppression of pancreatic tumor growth by targeted arsenic delivery with anti-CD44v6 single chain antibody conjugated nanoparticles","volume":"34","author":"Qian","year":"2013","journal-title":"Biomaterials"},{"key":"nanoad501abib30","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1021\/acsapm.1c01515","article-title":"Metal (Au)-decorated chitosan-l-arginine polymeric vector for codelivery of gefitinib and miR125b for lung cancer therapy","volume":"4","author":"Amgoth","year":"2022","journal-title":"ACS Appl. Polym. Mater."},{"key":"nanoad501abib31","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics: an emerging treatment modality for cancer","volume":"7","author":"Davis","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"nanoad501abib32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jddst.2019.04.016","article-title":"A G2\/M-phase specific drug delivery system based on increased exposure of phosphatidylethanolamine on mitotic cancer cells and low pH in tumor tissues","volume":"52","author":"Hong","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"nanoad501abib33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jconrel.2017.03.391","article-title":"Paclitaxel dimers assembling nanomedicines for treatment of cervix carcinoma","volume":"254","author":"Pei","year":"2017","journal-title":"J. Control. Release"},{"key":"nanoad501abib34","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3109\/10409239509083491","article-title":"The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance","volume":"30","author":"Hayes","year":"1995","journal-title":"Crit. Rev. Biochem. Mo. Biol."}],"container-title":["Nanotechnology"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ad501a","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ad501a\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ad501a","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ad501a\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ad501a\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ad501a\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ad501a\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ad501a\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T14:43:06Z","timestamp":1749912186000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6528\/ad501a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,7]]},"references-count":34,"journal-issue":{"issue":"34","published-online":{"date-parts":[[2024,6,7]]},"published-print":{"date-parts":[[2024,8,19]]}},"URL":"https:\/\/doi.org\/10.1088\/1361-6528\/ad501a","relation":{},"ISSN":["0957-4484","1361-6528"],"issn-type":[{"value":"0957-4484","type":"print"},{"value":"1361-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,7]]},"assertion":[{"value":"Dual approach: micellar delivery of chlorambucil prodrug with concurrent glutathione depletion and GST inhibition for enhanced anticancer activity","name":"article_title","label":"Article Title"},{"value":"Nanotechnology","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2024 IOP Publishing Ltd. All rights, including for text and data mining, AI training, and similar technologies, are reserved.","name":"copyright_information","label":"Copyright Information"},{"value":"2024-03-13","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2024-05-24","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2024-06-07","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}